Capital Research Global Investors Boosts CVS Health Stake

Investment firm increases holdings in pharmacy operator by 24.5%

Published on Mar. 11, 2026

Capital Research Global Investors, a major institutional investor, has increased its stake in CVS Health Corporation by 24.5%, adding 2,253,531 shares in the third quarter. The firm now owns 11,469,250 shares, or 0.90% of the pharmacy operator's stock, valued at $864,667,000.

Why it matters

This significant increase in ownership by a prominent investment firm signals confidence in CVS Health's long-term prospects, despite recent market volatility. As a major player in the healthcare and pharmacy industry, CVS Health's performance is closely watched by investors.

The details

According to a recent SEC filing, Capital Research Global Investors increased its holdings in CVS Health by 24.5% in the third quarter. The firm now owns 11,469,250 shares of the company's stock, valued at $864,667,000. This represents a 0.90% stake in CVS Health.

  • Capital Research Global Investors increased its CVS Health holdings in the third quarter of 2026.

The players

Capital Research Global Investors

A major institutional investment firm that has increased its stake in CVS Health Corporation.

CVS Health Corporation

A diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services, and health care solutions.

Got photos? Submit your photos here. ›

The takeaway

The significant increase in ownership by Capital Research Global Investors, a respected investment firm, suggests confidence in CVS Health's long-term growth potential despite recent market volatility. As a major player in the healthcare industry, CVS Health's performance remains closely watched by investors.